Eisai clinches Merck deal to develop and sell cancer drug, shares soar

NEW YORK/TOKYO (Reuters) - Merck& Co Inc and Japan's Eisai Co Ltd have signed a potential multibillion-dollar collaboration to develop and sell Eisai's cancer drug Lenvima, which is already approved in dozens of countries for two uses.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news